GB201504662D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB201504662D0
GB201504662D0 GBGB1504662.6A GB201504662A GB201504662D0 GB 201504662 D0 GB201504662 D0 GB 201504662D0 GB 201504662 A GB201504662 A GB 201504662A GB 201504662 D0 GB201504662 D0 GB 201504662D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1504662.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Verona Pharma PLC
Original Assignee
Verona Pharma PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma PLC filed Critical Verona Pharma PLC
Priority to GBGB1504662.6A priority Critical patent/GB201504662D0/en
Publication of GB201504662D0 publication Critical patent/GB201504662D0/en
Priority to PT17207623T priority patent/PT3332767T/en
Priority to NO15770593A priority patent/NO3193835T3/no
Priority to RS20211044A priority patent/RS62252B1/en
Priority to SI201531657T priority patent/SI3494962T1/en
Priority to ES15770593.0T priority patent/ES2670025T3/en
Priority to NZ729796A priority patent/NZ729796A/en
Priority to PL17207623T priority patent/PL3332767T3/en
Priority to CN201811561721.4A priority patent/CN110051627A/en
Priority to PL15770593T priority patent/PL3193835T3/en
Priority to RS20180519A priority patent/RS57227B1/en
Priority to DK15770593.0T priority patent/DK3193835T3/en
Priority to HUE15770593A priority patent/HUE038433T2/en
Priority to RU2017108432A priority patent/RU2699995C2/en
Priority to NZ767295A priority patent/NZ767295A/en
Priority to CN201580053062.1A priority patent/CN106794157B/en
Priority to NZ767296A priority patent/NZ767296A/en
Priority to LTEP15770593.0T priority patent/LT3193835T/en
Priority to US15/509,943 priority patent/US9956171B2/en
Priority to KR1020177006862A priority patent/KR102379309B1/en
Priority to SI201530213T priority patent/SI3193835T1/en
Priority to SI201530774T priority patent/SI3332767T1/en
Priority to PT191526292T priority patent/PT3494962T/en
Priority to LTEP19152629.2T priority patent/LT3494962T/en
Priority to EP19152629.2A priority patent/EP3494962B1/en
Priority to JP2017514346A priority patent/JP6860477B2/en
Priority to HUE17207623A priority patent/HUE045303T2/en
Priority to MX2017003102A priority patent/MX2017003102A/en
Priority to CN202010090019.5A priority patent/CN111249260B/en
Priority to DK19152629.2T priority patent/DK3494962T3/en
Priority to ES19152629T priority patent/ES2875584T3/en
Priority to CA2959943A priority patent/CA2959943C/en
Priority to HUE19152629A priority patent/HUE055527T2/en
Priority to AU2015316592A priority patent/AU2015316592B2/en
Priority to PL19152629T priority patent/PL3494962T3/en
Priority to PT157705930T priority patent/PT3193835T/en
Priority to EP15770593.0A priority patent/EP3193835B1/en
Priority to MYPI2017000391A priority patent/MY196072A/en
Priority to RS20190765A priority patent/RS58897B1/en
Priority to EP17207623.4A priority patent/EP3332767B1/en
Priority to LTEP17207623.4T priority patent/LT3332767T/en
Priority to BR112017005050-1A priority patent/BR112017005050B1/en
Priority to DK17207623.4T priority patent/DK3332767T3/en
Priority to PCT/GB2015/052668 priority patent/WO2016042313A1/en
Priority to SG11201701854WA priority patent/SG11201701854WA/en
Priority to ES17207623T priority patent/ES2730810T3/en
Priority to IL250895A priority patent/IL250895B/en
Priority to PH12017500479A priority patent/PH12017500479B1/en
Priority to US15/927,517 priority patent/US10945950B2/en
Priority to CY20181100455T priority patent/CY1120264T1/en
Priority to HRP20180833TT priority patent/HRP20180833T1/en
Priority to HK18108909.3A priority patent/HK1249415B/en
Priority to JP2018238014A priority patent/JP6795574B2/en
Priority to AU2018286571A priority patent/AU2018286571B2/en
Priority to CY20191100622T priority patent/CY1121698T1/en
Priority to HRP20191122TT priority patent/HRP20191122T1/en
Priority to AU2020203081A priority patent/AU2020203081B2/en
Priority to HRP20211035TT priority patent/HRP20211035T1/en
Priority to CY20211100720T priority patent/CY1124546T1/en
Ceased legal-status Critical Current

Links

GBGB1504662.6A 2014-09-15 2015-03-19 Formulation Ceased GB201504662D0 (en)

Priority Applications (59)

Application Number Priority Date Filing Date Title
GBGB1504662.6A GB201504662D0 (en) 2015-03-19 2015-03-19 Formulation
PT17207623T PT3332767T (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
NO15770593A NO3193835T3 (en) 2014-09-15 2015-09-15
RS20211044A RS62252B1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
SI201531657T SI3494962T1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
ES15770593.0T ES2670025T3 (en) 2014-09-15 2015-09-15 Formulation for liquid inhalation comprising RPL554
NZ729796A NZ729796A (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
PL17207623T PL3332767T3 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
CN201811561721.4A CN110051627A (en) 2014-09-15 2015-09-15 Liquid comprising RPL554 sucks preparation
PL15770593T PL3193835T3 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
RS20180519A RS57227B1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
DK15770593.0T DK3193835T3 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
HUE15770593A HUE038433T2 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
RU2017108432A RU2699995C2 (en) 2014-09-15 2015-09-15 Liquid inhalation composition containing rpl554
NZ767295A NZ767295A (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
CN201580053062.1A CN106794157B (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
NZ767296A NZ767296A (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
LTEP15770593.0T LT3193835T (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
US15/509,943 US9956171B2 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
KR1020177006862A KR102379309B1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
SI201530213T SI3193835T1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
SI201530774T SI3332767T1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
PT191526292T PT3494962T (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
LTEP19152629.2T LT3494962T (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
EP19152629.2A EP3494962B1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
JP2017514346A JP6860477B2 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation containing RPL554
HUE17207623A HUE045303T2 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
MX2017003102A MX2017003102A (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554.
CN202010090019.5A CN111249260B (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
DK19152629.2T DK3494962T3 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
ES19152629T ES2875584T3 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
CA2959943A CA2959943C (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
HUE19152629A HUE055527T2 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
AU2015316592A AU2015316592B2 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
PL19152629T PL3494962T3 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
PT157705930T PT3193835T (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
EP15770593.0A EP3193835B1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
MYPI2017000391A MY196072A (en) 2014-09-15 2015-09-15 Liquid Inhalation Formulation Comprising RPL554
RS20190765A RS58897B1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
EP17207623.4A EP3332767B1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
LTEP17207623.4T LT3332767T (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
BR112017005050-1A BR112017005050B1 (en) 2014-09-15 2015-09-15 LIQUID PHARMACEUTICAL COMPOSITIONS, NEBULIZER AND LIQUID PHARMACEUTICAL COMPOSITION USES
DK17207623.4T DK3332767T3 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising RPL554
PCT/GB2015/052668 WO2016042313A1 (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
SG11201701854WA SG11201701854WA (en) 2014-09-15 2015-09-15 Liquid inhalation formulation comprising rpl554
ES17207623T ES2730810T3 (en) 2014-09-15 2015-09-15 Formulation for liquid inhalation comprising RPL554
IL250895A IL250895B (en) 2014-09-15 2017-03-02 Liquid inhalation formulation comprising rpl554
PH12017500479A PH12017500479B1 (en) 2014-09-15 2017-03-14 Liquid inhalation formulation comprising rpl554
US15/927,517 US10945950B2 (en) 2014-09-15 2018-03-21 Liquid inhalation formulation comprising RPL554
CY20181100455T CY1120264T1 (en) 2014-09-15 2018-05-03 LIQUID PREPARATION FOR INHALATION CONTAINING RPL554
HRP20180833TT HRP20180833T1 (en) 2014-09-15 2018-05-25 Liquid inhalation formulation comprising rpl554
HK18108909.3A HK1249415B (en) 2014-09-15 2018-07-10 Liquid inhalation formulation comprising rpl554
JP2018238014A JP6795574B2 (en) 2014-09-15 2018-12-20 Liquid inhalation formulation containing RPL554
AU2018286571A AU2018286571B2 (en) 2014-09-15 2018-12-24 Liquid inhalation formulation comprising RPL554
CY20191100622T CY1121698T1 (en) 2014-09-15 2019-06-18 LIQUID INHALATION PREPARATION CONTAINING RPL554
HRP20191122TT HRP20191122T1 (en) 2014-09-15 2019-06-19 Liquid inhalation formulation comprising rpl554
AU2020203081A AU2020203081B2 (en) 2014-09-15 2020-05-11 Liquid inhalation formulation comprising RPL554
HRP20211035TT HRP20211035T1 (en) 2014-09-15 2021-06-30 Liquid inhalation formulation comprising rpl554
CY20211100720T CY1124546T1 (en) 2014-09-15 2021-08-10 LIQUID INHALATION PREPARATION CONTAINING RPL554

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1504662.6A GB201504662D0 (en) 2015-03-19 2015-03-19 Formulation

Publications (1)

Publication Number Publication Date
GB201504662D0 true GB201504662D0 (en) 2015-05-06

Family

ID=53052069

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1504662.6A Ceased GB201504662D0 (en) 2014-09-15 2015-03-19 Formulation

Country Status (1)

Country Link
GB (1) GB201504662D0 (en)

Similar Documents

Publication Publication Date Title
HK1256195A1 (en) Stable anti-ifnar1 formulation
GB201407934D0 (en) Formulation
GB201513010D0 (en) Novel formulation
GB201514758D0 (en) Formulation
GB201608356D0 (en) Formulation
RS62057B1 (en) Maropitant formulation
IL248835B (en) Ceritinib formulation
GB201407384D0 (en) Formulation
IL251362A0 (en) Formulation
GB201521771D0 (en) Formulation
GB201511255D0 (en) Formulation
GB201509891D0 (en) Formulation
GB201707615D0 (en) Formulation
GB201511301D0 (en) Formulation
PL3559185T3 (en) Clear-rinse formulation
GB201609925D0 (en) Formulation
GB201514014D0 (en) Formulation
GB201602048D0 (en) Formulation
GB201504662D0 (en) Formulation
GB201508527D0 (en) Novel formulation
GB201416536D0 (en) Formulation
GB201416274D0 (en) Formulation
GB201412754D0 (en) Formulation
GB201404773D0 (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)